- Home
- LGHL vs SBFM Comparison
LGHL vs SBFM Comparison
Compare LGHL & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGHL
- SBFM
- Stock Information
- Founded
- LGHL 2015
- SBFM 2006
- Country
- LGHL Singapore
- SBFM United States
- Employees
- LGHL N/A
- SBFM N/A
- Industry
- LGHL Investment Bankers/Brokers/Service
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- LGHL Finance
- SBFM Health Care
- Exchange
- LGHL Nasdaq
- SBFM Nasdaq
- Market Cap
- LGHL 4.3M
- SBFM 3.7M
- IPO Year
- LGHL N/A
- SBFM N/A
- Fundamental
- Price
- LGHL $0.16
- SBFM $2.90
- Analyst Decision
- LGHL
- SBFM Strong Buy
- Analyst Count
- LGHL 0
- SBFM 1
- Target Price
- LGHL N/A
- SBFM $15.00
- AVG Volume (30 Days)
- LGHL 5.4M
- SBFM 151.9K
- Earning Date
- LGHL 01-28-2025
- SBFM 11-05-2024
- Dividend Yield
- LGHL N/A
- SBFM N/A
- EPS Growth
- LGHL N/A
- SBFM N/A
- EPS
- LGHL N/A
- SBFM N/A
- Revenue
- LGHL $13,659,110.00
- SBFM $32,959,491.00
- Revenue This Year
- LGHL N/A
- SBFM $59.94
- Revenue Next Year
- LGHL N/A
- SBFM $164.69
- P/E Ratio
- LGHL N/A
- SBFM N/A
- Revenue Growth
- LGHL 11.35
- SBFM 61.94
- 52 Week Low
- LGHL $0.13
- SBFM $2.11
- 52 Week High
- LGHL $1.55
- SBFM $572.00
- Technical
- Relative Strength Index (RSI)
- LGHL 44.11
- SBFM 49.22
- Support Level
- LGHL $0.14
- SBFM $2.79
- Resistance Level
- LGHL $0.17
- SBFM $2.94
- Average True Range (ATR)
- LGHL 0.03
- SBFM 0.26
- MACD
- LGHL -0.00
- SBFM -0.03
- Stochastic Oscillator
- LGHL 10.64
- SBFM 16.70
About LGHL Lion Group Holding Ltd.
Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.